Cordlife Group Past Earnings Performance
Past criteria checks 0/6
Cordlife Group's earnings have been declining at an average annual rate of -24.9%, while the Healthcare industry saw earnings growing at 5.8% annually. Revenues have been declining at an average rate of 4.3% per year.
Key information
-24.9%
Earnings growth rate
-25.0%
EPS growth rate
Healthcare Industry Growth | 9.7% |
Revenue growth rate | -4.3% |
Return on equity | -9.0% |
Net Margin | -30.2% |
Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Cordlife Group Limited (SGX:P8A) Looks Inexpensive After Falling 30% But Perhaps Not Attractive Enough
May 06Risks Still Elevated At These Prices As Cordlife Group Limited (SGX:P8A) Shares Dive 31%
Mar 22Estimating The Fair Value Of Cordlife Group Limited (SGX:P8A)
Sep 07Cordlife Group (SGX:P8A) Will Be Hoping To Turn Its Returns On Capital Around
Aug 02Cordlife Group (SGX:P8A) Might Be Having Difficulty Using Its Capital Effectively
Apr 03Cordlife Group (SGX:P8A) Is Looking To Continue Growing Its Returns On Capital
Oct 15Cordlife Group's (SGX:P8A) Problems Go Beyond Weak Profit
Aug 22Revenue & Expenses Breakdown
How Cordlife Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 37 | -11 | 37 | 0 |
31 Mar 24 | 46 | -4 | 38 | 0 |
31 Dec 23 | 56 | 4 | 38 | 0 |
30 Sep 23 | 56 | 4 | 38 | 0 |
30 Jun 23 | 57 | 5 | 38 | 0 |
31 Mar 23 | 56 | 5 | 37 | 0 |
31 Dec 22 | 55 | 5 | 36 | 0 |
30 Sep 22 | 55 | 5 | 36 | 0 |
30 Jun 22 | 56 | 6 | 35 | 0 |
31 Mar 22 | 56 | 6 | 36 | 0 |
31 Dec 21 | 57 | 6 | 36 | 0 |
30 Sep 21 | 58 | 6 | 36 | 0 |
30 Jun 21 | 60 | 6 | 37 | 0 |
31 Mar 21 | 60 | 6 | 37 | 0 |
31 Dec 20 | 59 | 7 | 38 | 0 |
30 Sep 20 | 59 | 8 | 39 | 0 |
30 Jun 20 | 58 | 7 | 41 | 0 |
31 Mar 20 | 58 | 7 | 42 | 0 |
31 Dec 19 | 62 | 6 | 43 | 0 |
30 Sep 19 | 60 | 3 | 43 | 0 |
30 Jun 19 | 59 | 2 | 43 | 0 |
31 Mar 19 | 69 | 4 | 43 | 0 |
31 Dec 18 | 60 | 2 | 44 | 0 |
30 Jun 18 | 68 | 3 | 43 | 0 |
31 Mar 18 | 67 | 3 | 42 | 0 |
31 Dec 17 | 62 | -1 | 40 | 0 |
30 Sep 17 | 62 | -1 | 40 | 0 |
30 Jun 17 | 60 | -3 | 39 | 0 |
31 Mar 17 | 60 | -6 | 41 | 0 |
31 Dec 16 | 60 | -7 | 40 | 0 |
30 Sep 16 | 60 | 4 | 39 | 0 |
30 Jun 16 | 60 | 12 | 38 | 0 |
31 Mar 16 | 60 | 36 | 37 | 0 |
31 Dec 15 | 59 | 56 | 36 | 0 |
30 Sep 15 | 59 | 43 | 36 | 0 |
30 Jun 15 | 58 | 32 | 35 | 0 |
31 Mar 15 | 56 | 28 | 32 | 0 |
31 Dec 14 | 53 | 11 | 31 | 0 |
30 Sep 14 | 51 | 18 | 29 | 0 |
30 Jun 14 | 49 | 31 | 27 | 0 |
31 Mar 14 | 45 | 18 | 25 | 0 |
31 Dec 13 | 40 | 18 | 23 | 0 |
30 Sep 13 | 37 | 19 | 20 | 0 |
Quality Earnings: P8A is currently unprofitable.
Growing Profit Margin: P8A is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: P8A is unprofitable, and losses have increased over the past 5 years at a rate of 24.9% per year.
Accelerating Growth: Unable to compare P8A's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: P8A is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-35.5%).
Return on Equity
High ROE: P8A has a negative Return on Equity (-8.95%), as it is currently unprofitable.